| SGX Healthcare Index Chalked Up 19.6% Total Return in First 7 Months of 2015 |
|
Singapore’s Healthcare Sector includes companies that provide hospital, clinical and ancillary services to providers of medical supplies, ranging from cleanroom attire to high-tech medical equipment and providers of pharmaceuticals, including western and traditional Chinese medicines.
Providing a benchmark for the expanding sector, the SGX Healthcare Index is an indicative index computed by Singapore Exchange (SGX), and weightings of component stocks are capped at a maximum of 10% at each semi-annual rebalance so that it is better diversified across a range of companies.
Due to the relative market capitalisations of the 29 securities, the six largest constituents currently account for approximately 60% of the index weight. These six stocks- namely, IHH Healthcare Berhad, Raffles Medical Group, Haw Par Corporation, Parkway Life Real Estate Investment Trust, Tianjin Zhongxin Pharmaceutical Group Corporation and Biosensors International Group, were discussed in last month’s Market Update - Six Largest Stocks in SGX Healthcare Index Averaged Total Returns of 19% YTD (click here).
The objective of the Index is to capture a broad representation of the healthcare segment, and complements the healthcare stocks under the two classification standards – Global Industry Classification Standard (GICS®) and Industry Classification Benchmark (ICB). These 29 components are categorised across sub-industries including healthcare equipment, healthcare supplies, healthcare distributors, healthcare services, healthcare facilities, pharmaceuticals, office services & supplies, and healthcare REITs.
The charts below illustrates the performance of the Index on a total return basis since a base price of 1000 on 30 June 2011. The Index closed Friday at 2198.6.
Largest Index Constituents in July
The 20 largest healthcare plays are detailed in the table below. Please note that clicking on a stock name will take you to its relevant profile page on StockFacts. A total of 19 of these 20 stocks are included in the SGX Healthcare Index and make up the majority weighting of the Index.
These stocks averaged a 3.7% decline over July, with the positive performances of three of the Index’s heavyweights accounting for the lesser decline of the Index at 1.5%. Other stocks that are included in the SGX Healthcare Index are Techcomp (Holdings), UG Healthcare Corporation, Singapore Medical Group, Vicplas International, AsiaMedic, Medtecs International Corporation, Suntar Eco-City, STAR Pharmaceutical, Pharmesis International and Pacific Healthcare Holdings.
iX Biopharma was listed on Catalist last month. The stock closed Friday at 41.5 cents, 9.8% below the offer price and offer details can be found here. The company focuses on the development and commercialisation of innovative therapies for pain management and male erectile dysfunction. The Company leverages its patented sublingual drug delivery technology, WaferiXTM, to develop proprietary products that incorporate FDA-approved pharmacologically active compounds. The Group currently have three drugs under development – Wafermine™, Wafernyl™ and PheoniX™.
The Group operates an integrated business model encompassing drug development, manufacturing and supply.
Source: My Gateway
Want to receive more frequent Trading Ideas in your Email or SMS? Open a Free Trading Account with us now! http://bit.ly/1gegCv0
|
Thursday, August 13, 2015
Singapore Healthcare Index Chalked Up 19.6% Total Return in First 7 Months of 2015
